These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 35083754)

  • 1. Preventing driveline infection during left ventricular assist device support by the HeartMate 3: A survey-based study.
    Saeed O; Moss N; Barrus B; Vidula H; Shah S; Feitell S; Masser KS; Kilic A; Moin D; Atluri P; Barati E
    Artif Organs; 2022 Jul; 46(7):1409-1414. PubMed ID: 35083754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular assist device driveline infections in three contemporary devices.
    Schlöglhofer T; Michalovics P; Riebandt J; Angleitner P; Stoiber M; Laufer G; Schima H; Wiedemann D; Zimpfer D; Moscato F
    Artif Organs; 2021 May; 45(5):464-472. PubMed ID: 33052592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of an improved driveline management for HeartMate II and HeartMate 3 left ventricular assist devices.
    Mutsuga M; Okumura T; Morimoto R; Kondo T; Ito H; Terazawa S; Tokuda Y; Narita Y; Nishida K; Murohara T; Usui A
    Artif Organs; 2023 Feb; 47(2):387-395. PubMed ID: 36269680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Driveline Infection in Left Ventricular Assist Device Patients: Effect of Standardized Protocols, Pathogen Type, and Treatment Strategy.
    Lumish HS; Cagliostro B; Braghieri L; Bohn B; Mondellini GM; Antler K; Feldman V; Kleet A; Murphy J; Tiburcio M; Fidlow K; Jennings D; Sayer GT; Takeda K; Naka Y; Demmer RT; Aaron JG; Uriel N; Colombo PC; Yuzefpolskaya M
    ASAIO J; 2022 Dec; 68(12):1450-1458. PubMed ID: 35239537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention and early treatment of driveline infections in ventricular assist device patients - The DESTINE staging proposal and the first standard of care protocol.
    Bernhardt AM; Schlöglhofer T; Lauenroth V; Mueller F; Mueller M; Schoede A; Klopsch C;
    J Crit Care; 2020 Apr; 56():106-112. PubMed ID: 31896443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic negative pressure wound therapy is not effective for preventing driveline infection following left ventricular assist device implantation.
    Tsuji M; Kakuda N; Bujo C; Saito A; Ishida J; Amiya E; Hatano M; Shimada A; Imai H; Kimura M; Ando M; Kinoshita O; Yamauchi H; Komuro I; Ono M
    Artif Organs; 2023 Mar; 47(3):566-573. PubMed ID: 36300650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel driveline route for prevention from driveline infection: Triple tunnel method.
    Yoshitake S; Kinoshita O; Nawata K; Hoshino Y; Itoda Y; Kimura M; Yamauchi H; Ono M
    J Cardiol; 2018 Oct; 72(4):363-366. PubMed ID: 29731190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of chlorhexidine gluconate intolerance on driveline infection during chronic HeartMate II left ventricular assist device support.
    Son AY; Stein LH; DeAnda A; Katz SD; Smith DE; Reyentovich A; Balsam LB
    Int J Artif Organs; 2017 Jan; 39(11):570-574. PubMed ID: 28085173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous-flow left ventricular assist devices and usefulness of a standardized strategy to reduce drive-line infections.
    Cagliostro B; Levin AP; Fried J; Stewart S; Parkis G; Mody KP; Garan AR; Topkara V; Takayama H; Naka Y; Jorde UP; Uriel N
    J Heart Lung Transplant; 2016 Jan; 35(1):108-114. PubMed ID: 26476767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ventricular Assist Device Driveline Infections: A Systematic Review.
    Krzelj K; Petricevic M; Gasparovic H; Biocina B; McGiffin D
    Thorac Cardiovasc Surg; 2022 Sep; 70(6):493-504. PubMed ID: 34521143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity Is Associated with Driveline Infection of Left Ventricular Assist Devices.
    Akay MH; Nathan SS; Radovancevic R; Poglajen G; Jezovnik MK; Candelaria IN; Averill BL; Patel MK; Kar B; Gregoric ID
    ASAIO J; 2019; 65(7):678-682. PubMed ID: 30398982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Driveline Infection Risk with Utilization of a Temporary External Anchoring Suture After Implantation of a Left Ventricular Assist Device.
    Fudim M; Brown CL; Davis ME; Djunaidi M; Danter MR; Harrell FE; Stulak JM; Haglund NA; Maltais S
    ASAIO J; 2016; 62(3):291-6. PubMed ID: 26809083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Driveline Features as Risk Factor for Infection in Left Ventricular Assist Devices: Meta-Analysis and Experimental Tests.
    Kranzl M; Stoiber M; Schaefer AK; Riebandt J; Wiedemann D; Marko C; Laufer G; Zimpfer D; Schima H; Schlöglhofer T
    Front Cardiovasc Med; 2021; 8():784208. PubMed ID: 34977190
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention, treatment and outcomes of left ventricular assist device driveline infections. A single Center experience.
    Putnik S; Terzić D; Nestorović E; Karan R; Dobri M; Andrijasević V; Zlatkovic M; Kostić NK; Velinovic M; Ivanisevic D; Ristić M
    Ann Ital Chir; 2020; 91():8-15. PubMed ID: 32180572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low Incidence of Pump-Related Infections in Jarvik 2000 Ventricular Assist Device Recipients with a Subcostal Driveline Exit Site.
    Letsou GV; Anand J; Ogburn E; Shah RM; Ganapathy AV; Cohn WE; Loor G; Frazier OH
    Tex Heart Inst J; 2019 Jun; 46(3):179-182. PubMed ID: 31708699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of modular cable exchange in HeartMate 3 patients versus conventional driveline repair in HeartMate II patients.
    Merzah AS; Hanke JS; Li T; Saad Merzah FA; Gabriel M; Derda AA; Homann K; Haverich A; Schmitto JD; Dogan G
    Artif Organs; 2023 Feb; 47(2):380-386. PubMed ID: 36148849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Driveline infections in left ventricular assist devices: implications for destination therapy.
    Sharma V; Deo SV; Stulak JM; Durham LA; Daly RC; Park SJ; Baddour LM; Mehra K; Joyce LD
    Ann Thorac Surg; 2012 Nov; 94(5):1381-6. PubMed ID: 22818961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Jarvik 2000 is associated with less infections than the HeartMate left ventricular assist device.
    Siegenthaler MP; Martin J; Pernice K; Doenst T; Sorg S; Trummer G; Friesewinkel O; Beyersdorf F
    Eur J Cardiothorac Surg; 2003 May; 23(5):748-54; discussion 754-5. PubMed ID: 12754028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability in infection control measures for the percutaneous lead among programs implanting long-term ventricular assist devices in the United States.
    Cannon A; Elliott T; Ballew C; Cavey J; O'Shea G; Franzwa J; Puhlman M; Bennett J; Ryan T; Lockard K; Avrahami N; Brennan P; Kurien S; Andrus S; Dick S; Davis E
    Prog Transplant; 2012 Dec; 22(4):351-9. PubMed ID: 23187051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular assist systems and infection-related outcomes: A comprehensive analysis of the MOMENTUM 3 trial.
    Patel CB; Blue L; Cagliostro B; Bailey SH; Entwistle JW; John R; Thohan V; Cleveland JC; Goldstein DJ; Uriel N; Su X; Somo SI; Sood P; Mehra MR
    J Heart Lung Transplant; 2020 Aug; 39(8):774-781. PubMed ID: 32276809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.